[1] DAHI VN, MØIHAVE M, FIØE A, et al. Global trends of pulmonary infections with nontuberculous Mycobacteria: a systematic review[J]. International Journal of Infectious Diseases, 2022, 125: 120-131. [2] 中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版)[J]. 中华结核和呼吸杂志, 2020, 43(11): 918-946. [3] NQWATA L, OUEDRAGO AR.Non-tuberculous Mycobacteria pulmonary disease: A review of trends, risk factors, diagnosis and management[J]. African Journal of Thoracic and Critical Care Medicine, 2022, 28(2):82-86. [4] MATHEMA B, KUREPINA NE, BIFANI PJ, et al.Molecular epidemiology of tuberculosis: current insights[J]. Clin Microbiol Rev, 2006, 19(4): 658-685. [5] XU X, LEI Y, ZHENG L.Non-tuberculous Mycobacterial infections in mainland China and Taiwan: a systematic review and meta-analysis of epidemiology, species distribution, and drug resistance (2013-2024)[J]. Frontiers in Public Health, 2025, 13: 1676715. [6] 中华医学会结核病学分会, 非结核分枝杆菌病实验室诊断专家共识编写组. 非结核分枝杆菌病实验室诊断专家共识[J]. 中华结核和呼吸杂志, 2016, 39(6): 438-443. [7] 黄莉雅, 李琪, 王丽芳, 等. 非结核分枝杆菌肺病的诊疗研究进展[J]. 海南医学院学报, 2024, 30(7): 545-549. [8] LEE H, MYUNG W, KOH WJ, et al.Epidemiology of nontuberculous Mycobacterial infection, South Korea, 2007-2016[J]. Emerging Infectious Diseases, 2019, 25(3): 569-572. [9] TAN Y, SU B, SHU W, et al.Epidemiology of pulmonary disease due to nontuberculous Mycobacteria in Southern China, 2013-2016[J]. BMC Pulm Med, 2018, 18(1): 168. [10] 刘超, 刁婷婷, 李晓非. 2012-2022年云南地区非结核分枝杆菌肺病感染情况及耐药性分析[J]. 云南医药, 2023, 44(5): 10-14. [11] 张汇征, 陈耀凯, 严晓峰, 等. 重庆市流行非结核分枝杆菌菌种鉴定及感染人群特征[J]. 中国热带医学, 2019, 19(4): 330-334. [12] 吴海丰, 翁敏华, 刘瑞, 等. 海南地区225例非结核分枝杆菌肺病流行状况和临床特征[J]. 中国热带医学, 2024, 24(4): 463-467. [13] 陈宇飞, 宋其生. 大连地区非结核分枝杆菌肺病患者流行病学及临床特点研究[J/CD]. 中国医学前沿杂志(电子版), 2023, 15(8): 28-32. [14] ZHANG Y, HOU D, WANG S, et al.非结核分枝杆菌肺病临床分离株的菌种鉴定及临床特征分析[J]. 微生物与感染, 2020, 15(3): 172-178. [15] 刘海涛, 田杰, 韩云艳, 等. 2016-2021年唐山地区非结核分枝杆菌流行及耐药情况分析[J/CD]. 新发传染病电子杂志, 2023, 8(6): 58-62. [16] WINTHROP K L, MARRA T K, ADJEMIAN J, et al.Incidence and prevalence of nontuberculous Mycobacterial lung disease in a large U.S. managed care health plan, 2008-2015[J]. Ann Am Thorac Soc, 2020, 17(2): 178-185. [17] PRATO BD, ALTIERI AM, CARLUCCI B, et al.Non-tuberculous Mycobacterial pulmonary disease: an Italian National survey[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2018, 35(1): 21-25. [18] 陈华, 赖晓宇, 陈品儒, 等. 广州地区2018-2021年非结核分枝杆菌临床分离株菌种鉴定结果分析[J]. 实用医学杂志, 2022, 38(17): 2191-2197. [19] 李诞, 崔檬, 王佳贺. 老年人常见未分化疾病: 消瘦的流行病学及诊治进展[J]. 实用老年医学, 2022, 36(3): 223-227. [20] 张锡林, 钟永辉, 何芷慧, 等. 73例非结核分枝杆菌肺病患者临床特点分析[J]. 临床肺科杂志, 2019, 24(2): 212-216. [21] TAN Y, DENG Y, YAN X, et al.Nontuberculous Mycobacterial pulmonary disease and associated risk factors in China: a prospective surveillance study[J]. J Infect, 2021, 83(1): 46-53. [22] DHEDA K.Improving outcomes in patients with non-tuberculous Mycobacterial disease: is there light at the end of the tunnel?[J]. Eur Respir J, 2019, 54(1): 1901149. [23] KUMAR K, PONNUSWAMY A, CAPSTICK TG, et al.Non-tuberculous Mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management[J]. Clinical Medicine, 2024, 24(1): 100017. |